Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers

McKayla J Riggs; Miranda Lin; Joseph Kim; Prakash Pandalai; Charles S Dietrich 3rd

doi:10.1016/j.gore.2020.100610

Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers

Gynecol Oncol Rep. 2020 Jul 10:33:100610. doi: 10.1016/j.gore.2020.100610. eCollection 2020 Aug.

Authors

McKayla J Riggs¹, Miranda Lin², Joseph Kim², Prakash Pandalai², Charles S Dietrich 3rd¹

Affiliations

¹ Division of Gynecologic Oncology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States.
² Division of Surgical Oncology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States.

Abstract

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a key component of treatment in non-gynecologic peritoneal surface malignancies. As many as 10-15% of patients with a gastrointestinal primary malignancy will present with carcinomatosis. Maximal cytoreductive surgery directly affects the prognosis of patients. The routine inclusion of hysterectomy with bilateral salpingo-oophorectomy during these procedures optimizes cytoreduction despite negative pre-operative imaging and findings at the time of surgery. In this case series, we review twenty non-gynecologic cancer patients who underwent cytoreductive surgery with concurrent hysterectomy and bilateral salpingo-oophorectomy and HIPEC at our institution.

Keywords: Bilateral salpingo-oophorectomy; HIPEC; Hysterectomy.

Publication types

Case Reports